Search research articles
Contact Us
Filters
Showing results (111-120 of 139) with videos related to
Page
of 14
Sort By:
JAMA Health Forum
|
October 11, 2022
Estimating Rebates and Other Discounts Received by Medicare Part D
William B Feldman, Benjamin N Rome, Véronique C Raimond, et al.
JAMA Internal Medicine
|
November 27, 2023
Cost of Exempting Sole Orphan Drugs From Medicare Negotiation
Matthew Vogel, Olivia Zhao, William B Feldman, et al.
JAMA Dermatology
|
February 21, 2024
Use of Efficiency Frontiers to Align Prices and Clinical Benefits of Biologic Therapies for Plaque Psoriasis
Alexander C Egilman, Aaron S Kesselheim, Jerry Avorn, et al.
JAMA Network Open
|
May 22, 2026
Changes in the Use of Montelukast for Asthma After a US Food and Drug Administration Boxed Warning
Hariharan Shanmugam, Aaron S Kesselheim, Ian T T Liu, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 13, 2023
Identifying therapeutic alternatives in Medicare drug price negotiation: The case of etanercept
Helen Mooney, Matthew Martin, Liam Bendicksen, et al.
Health Affairs Scholar
|
June 26, 2026
Using prescription drug data for timely assessments of state insurance coverage rates: a validation study
Benjamin N Rome, Adrianna McIntyre, Jinwoo Kim, et al.
JAMA Internal Medicine
|
November 24, 2025
Characteristics of Speakers at US FDA Advisory Committee Meetings on Drug Approval
Leah Z Rand, Helen Mooney, Dongzhe Hong, et al.
The Journal of Arthroplasty
|
April 2, 2014
A comparison of patient-reported and measured range of motion in a cohort of total knee arthroplasty patients
Jamie E Collins, Benjamin N Rome, Meghan E Daigle, et al.
JAMA Oncology
|
April 3, 2025
Changes in Oncology Medication Use After Withdrawal of Accelerated Approval
Catherine S Hwang, Aaron S Kesselheim, Amar H Kelkar, et al.
JAMA Health Forum
|
January 27, 2023
Simulated Medicare Drug Price Negotiation Under the Inflation Reduction Act of 2022
Benjamin N Rome, Sarosh Nagar, Alexander C Egilman, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 139) with videos related to
Sort By:
Page
of 14
JAMA Health Forum
|
October 11, 2022
Estimating Rebates and Other Discounts Received by Medicare Part D
William B Feldman, Benjamin N Rome, Véronique C Raimond, et al.
JAMA Internal Medicine
|
November 27, 2023
Cost of Exempting Sole Orphan Drugs From Medicare Negotiation
Matthew Vogel, Olivia Zhao, William B Feldman, et al.
JAMA Dermatology
|
February 21, 2024
Use of Efficiency Frontiers to Align Prices and Clinical Benefits of Biologic Therapies for Plaque Psoriasis
Alexander C Egilman, Aaron S Kesselheim, Jerry Avorn, et al.
JAMA Network Open
|
May 22, 2026
Changes in the Use of Montelukast for Asthma After a US Food and Drug Administration Boxed Warning
Hariharan Shanmugam, Aaron S Kesselheim, Ian T T Liu, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 13, 2023
Identifying therapeutic alternatives in Medicare drug price negotiation: The case of etanercept
Helen Mooney, Matthew Martin, Liam Bendicksen, et al.
Health Affairs Scholar
|
June 26, 2026
Using prescription drug data for timely assessments of state insurance coverage rates: a validation study
Benjamin N Rome, Adrianna McIntyre, Jinwoo Kim, et al.
JAMA Internal Medicine
|
November 24, 2025
Characteristics of Speakers at US FDA Advisory Committee Meetings on Drug Approval
Leah Z Rand, Helen Mooney, Dongzhe Hong, et al.
The Journal of Arthroplasty
|
April 2, 2014
A comparison of patient-reported and measured range of motion in a cohort of total knee arthroplasty patients
Jamie E Collins, Benjamin N Rome, Meghan E Daigle, et al.
JAMA Oncology
|
April 3, 2025
Changes in Oncology Medication Use After Withdrawal of Accelerated Approval
Catherine S Hwang, Aaron S Kesselheim, Amar H Kelkar, et al.
JAMA Health Forum
|
January 27, 2023
Simulated Medicare Drug Price Negotiation Under the Inflation Reduction Act of 2022
Benjamin N Rome, Sarosh Nagar, Alexander C Egilman, et al.
Page
of 14